These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3496938)

  • 61. Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine , an analog of MPTP, on mouse heart norepinephrine and brain catecholamines.
    Hemrick-Luecke SK; Mitch CH; Quimby SJ; Fuller RW
    Neurochem Int; 1993 Nov; 23(5):467-70. PubMed ID: 8251928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults.
    Gupta M; Gupta BK; Thomas R; Bruemmer V; Sladek JR; Felten DL
    Neurosci Lett; 1986 Oct; 70(3):326-31. PubMed ID: 3490639
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
    Lau YS; Fung YK
    Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Perry TL; Hansen S; Jones K
    Neurosci Lett; 1987 Feb; 74(2):217-20. PubMed ID: 3494963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M; Neff NH
    J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
    Kulak JM; McIntosh JM; Quik M
    Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
    Pileblad E; Nissbrandt H; Carlsson A
    J Neural Transm; 1984; 60(3-4):199-203. PubMed ID: 6084705
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Age-related susceptibility to MPTP-induced neurotoxicity in mice.
    Ali SF; David SN; Newport GD
    Neurotoxicology; 1993; 14(1):29-34. PubMed ID: 8361676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
    Jonsson G; Sundström E; Mefford I; Olson L; Johnson S; Freedman R; Hoffer B
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):1-6. PubMed ID: 3877877
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
    Chiueh CC; Markey SP; Burns RS; Johannessen JN; Pert A; Kopin IJ
    Eur J Pharmacol; 1984 Apr; 100(2):189-94. PubMed ID: 6203759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin.
    Ueki A; Chong PN; Albanese A; Rose S; Chivers JK; Jenner P; Marsden CD
    Neuropharmacology; 1989 Oct; 28(10):1089-97. PubMed ID: 2510050
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Deutch AY; Elsworth JD; Goldstein M; Fuxe K; Redmond DE; Sladek JR; Roth RH
    Neurosci Lett; 1986 Jul; 68(1):51-6. PubMed ID: 3487756
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Donnan GA; Willis GL; Kaczmarczyk SJ; Rowe P
    J Neurol Sci; 1987 Feb; 77(2-3):185-91. PubMed ID: 3493329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.